Who’s Going to ASGCT 2027

May 3–7, 2027 Philadelphia, PA ~8k attendees Website

120 exhibitors at the American Society of Gene & Cell Therapy (ASGCT) 30th Annual Meeting, an ~8,000-person, mostly biopharma meeting of gene and cell therapy researchers. As of Oct 29, 2026.

Speakers and other attendees will be added as ASGCT 2027 gets closer.

Focus area
Showing 1–20 of 120 organizations
OrganizationASGCT 2027 Attendance
AAVnerGene
Rockville, MD
Reagent and consumables suppliers
AAV specialist offering vector design, packaging, capsid libraries and engineered capsids, characterization services, and catalog AAV plasmids, viruses and reagents.
Booth
Exhibiting at Booth 1112
Admera Health
South Plainfield, NJ
Analytical and testing service companies
Genomics and multi-omics service lab offering RNA, single-cell, spatial, whole-genome and epigenetic sequencing with bioinformatics for researchers and drug developers.
Booth
Exhibiting at Booth 907
AGC Biologics
Bothell, WA
Contract manufacturers (CDMOs)
Contract developer and manufacturer of protein biologics, cell and gene therapies and mRNA, with GMP sites across three continents.
Booth
Exhibiting at Booth 707
Altasciences
Laval, QC, Canada
Preclinical and discovery CROs
Drug development CRO running preclinical safety and clinical pharmacology studies, with bioanalysis, formulation, manufacturing and data services.
Booth
Exhibiting at Booth 500
Contract manufacturers (CDMOs)
Viral vector CDMO for gene therapy, covering plasmid engineering, process and analytical development, and clinical and commercial GMP production of AAV and other vectors.
Booth
Exhibiting at Booth 237
Ansa Biotechnologies
Emeryville, CA
Reagent and consumables suppliers
Makes synthetic DNA with an enzymatic synthesis platform, supplying clonal plasmids and sequence-verified linear fragments, including complex sequences, under an on-time delivery guarantee.
Booth
Exhibiting at Booth 945
Reagent and consumables suppliers
Makes GMP-grade nucleases for bioprocessing that strip residual DNA during viral vector manufacturing, working at high-salt or physiological salt conditions.
Booth
Exhibiting at Booth 1143
Reagent and consumables suppliers
Sells AI-guided genetic design and stable producer cell line platforms for lentivirus and AAV, plus mRNA expression optimization, to biologics and genetic medicine developers.
Booth
Exhibiting at Booth 1127
Gene and cell therapy developers
Gene therapy developer and Bayer subsidiary building AAV treatments for Parkinson's disease, heart failure and other rare and common conditions.
Booth
Exhibiting at Booth 422
Analytical and testing service companies
Analytical and bioanalytical testing lab for cell and gene therapies: potency assays, biodistribution, immunogenicity, cell bank characterization and NGS safety testing.
Booth
Exhibiting at Booth 504
Axolabs
Kulmbach, Germany
Contract manufacturers (CDMOs)
Contract research and manufacturing partner for oligonucleotide and other nucleic acid therapeutics, from discovery through clinical and commercial supply, with German and US sites.
Booth
Exhibiting at Booth 1506
Bio-Rad
Hercules, CA
Instrument and equipment makers
Makes droplet digital PCR and other instruments and reagents for measuring viral titer, vector purity, copy number and cell phenotype in cell and gene therapy.
Booth
Exhibiting at Booth 815
Reagent and consumables suppliers
Supplies GMP cytokines and growth factors, antibodies, small molecules and analytical instruments through brands including R&D Systems, Tocris, Novus Biologicals and ProteinSimple.
Booth
Exhibiting at Booth 1201
Analytical and testing service companies
Bioanalytical lab providing pharmacokinetic, immunogenicity, biomarker and CMC testing under GxP for drug developers, with sites in the US, Australia and Germany.
Booth
Exhibiting at Booth 805
Biocytogen
Waltham, MA
Preclinical and discovery CROs
Preclinical CRO offering off-the-shelf humanized and gene-edited mouse models, custom model generation, efficacy and pharmacology studies, and fully human antibody discovery.
Booth
Exhibiting at Booth 502
Boreal Biomanufacturing
Ottawa, ON, Canada
Hospitals and academic medical centers
The Ottawa Hospital's not-for-profit manufacturing centre, formerly its Biotherapeutics Manufacturing Centre, making viral vector, cell therapy and oncolytic virus products for early-phase trials.
Booth
Exhibiting at Booth 223
BPS Bioscience
San Diego, CA
Reagent and consumables suppliers
Makes recombinant proteins, assay kits, engineered cell lines and ready-to-use lentiviruses for drug discovery research.
Booth
Exhibiting at Booth 1542
c-LEcta
Leipzig, Germany
Reagent and consumables suppliers
Develops and produces engineered enzymes for food, feed and pharmaceutical uses, including nucleases for removing DNA in biologics and viral vector processing; part of Kerry.
Booth
Exhibiting at Booth 1213
Catalent
Bridgewater, NJ
Contract manufacturers (CDMOs)
Contract developer and manufacturer of AAV vectors and CAR-T cell therapies, with clinical and commercial production plus fill-finish and packaging in the US and Europe.
Booth
Exhibiting at Booth 525
Cellares
South San Francisco, CA
Contract manufacturers (CDMOs)
Cell therapy development and manufacturing provider that runs clinical and commercial production on its own automated, high-throughput manufacturing platform.
Booth
Exhibiting at Booth 413

Explore the full ASGCT 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Philadelphia. Leave your work email and we’ll be in touch.

Privacy

Download the full ASGCT 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from companies at ASGCT 2027

Tell us what you sell and we’ll find the people at these companies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

When and where is ASGCT 2027?

ASGCT 30th Annual Meeting runs May 3–7, 2027, at the Pennsylvania Convention Center in Philadelphia, PA.

Where is the ASGCT 2027 floor plan?

See the organizer’s interactive exhibit hall floor plan. This guide gives each exhibitor’s booth number.

How do I register for ASGCT 2027?

Fees and registration are on the organizer's registration page.

What is ASGCT 2027?

The 30th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), held May 3–7, 2027 at the Pennsylvania Convention Center in Philadelphia. It is the largest yearly meeting of the gene and cell therapy field — nearly 8,000 people came in 2026, mostly from industry, with about one in three from academia — and its exhibit hall gathers the manufacturers, tool makers, service companies and therapy developers that serve them.

What is in this guide?

Every organization exhibiting at ASGCT 2027 so far: 120 exhibitors with their booth numbers from the public floor plan — 120 organizations in one list, each typed and tagged with up to three focus areas, and a short description for 120.

Where is the program?

ASGCT has not published its 2027 scientific program yet. It will appear on the meeting’s Program + Workshops page and in its interactive program planner, expected in spring 2027; this guide will add the organizations on it then. Today it lists who is exhibiting, from the public exhibit floor plan.

Where does this list come from?

The organizer’s own public exhibit floor plan and the profile each exhibitor published on it — address, website, product categories and a company description. 91 of the 120 exhibitor listings had published a description and 74 a list of product categories; where an exhibitor published none, the short description is condensed from its own website or states what is well established about it. Nothing here requires a login.

How are organizations typed?

By what each organization sells or does for gene and cell therapy: contract manufacturers, reagent and plasmid suppliers, instrument and bioprocess equipment makers, analytical and testing services, research CROs and other services, software and data — then the therapy developers themselves, and the societies, patient groups and research institutes. The focus tags (at most three each) are judged from each exhibitor’s own profile and website.

How current is it?

Pulled from the public floor plan on October 29, 2026. Exhibitors keep signing up until the meeting, so the list will grow.

Why are there no names?

This guide is about which organizations are in the room, not which people. It never publishes a person’s name.

Browse ASGCT 2027 by

Exhibit hall

Organizations with their own page

120 organizations — every exhibitor and every organization with 1 or more presentations.

Not affiliated with the American Society of Gene & Cell Therapy. Organization details are derived from ASGCT’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction